Search

everythinglearnresearchcommunity

for

Search:↓

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Canadian lawsuits involving 5-alpha-reductase inhibitors are related to persistent erectile dysfunction side effects, with no judgments against companies yet.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

A young man had rare serious side effects from an epilepsy drug, leading to stopping the drug.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

The K5 promoter controls gene expression in skin cells, with specific DNA segments crucial for targeting and regulation.

Lipin-1 is important for skin cell differentiation and skin barrier function.

Platelet-rich plasma treatments reduce knee osteoarthritis inflammation, with pure PRP being more effective.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.